Achieve Life Sciences, Inc. ACHV
6.78 USD +0.06 (+0.89%)
Regular-session close
6.71 -0.07 -1.03%
After hours · Nov 9, 4:00 PM ET
6.52 Day range 6.91
2.62 52-week range 8.64
- YTD
- +5.12%
- 1 year
- +5.12%
News
benzinga.com CORRECTION: Achieve Life Sciences Q3 EPS $(0.11) Beats $(0.20) Estimate. Cash & Equivalents $201.5M Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.20) by 45 percent. This is a 60.71 percent increase over losses of…
globenewswire.com Achieve Life Sciences Becomes AchieveRx, The Quit Company, and Will Trade Under the Ticker QUIT SEATTLE and VANCOUVER, British Columbia, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) today announced that it has rebranded and will now be doing business as…
globenewswire.com Achieve Life Sciences Announces Granting of New Hire Inducement Awards SEATTLE and VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development…
globenewswire.com Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026 Nearly one in three adults who were still smoking or vaping after a prior ORCA trial had quit at the end of a year of cytisinicline treatment, with quit rates rising through the year Among the…
globenewswire.com Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications SEATTLE and VANCOUVER, British Columbia, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve and the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused…
globenewswire.com Achieve Life Sciences Announces Granting of New Hire Inducement Awards SEATTLE and VANCOUVER, British Columbia, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused…
defenseworld.net Achieve Life Sciences (NASDAQ:ACHV) Shares Gap Up – Here’s What Happened Achieve Life Sciences, Inc. (NASDAQ: ACHV - Get Free Report)'s stock price gapped up before the market opened on Wednesday. The stock had previously closed at $7.69, but opened at $8.08. Achieve Life…
globenewswire.com Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer Brings public company CFO experience across commercial pharma and business development as Achieve prepares for potential commercialization of cytisinicline Brings public company CFO experience across…
globenewswire.com Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026 SEATTLE and VANCOUVER, British Columbia, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development…
seekingalpha.com Achieve Life Sciences: Thesis Intact, Setup Remains Constructive (Rating Downgrade) Achieve Life Sciences is rated a 'buy' as it nears a second NDA resubmission after resolving prior manufacturing issues. ACHV's FDA setback was manufacturing-related, not efficacy or safety, with two…
seekingalpha.com Achieve Life Sciences: A Funded Manufacturing Reset, Not A Broken Clinical Thesis Achieve Life Sciences is navigating a manufacturing reset for cytisinicline following a Complete Response Letter citing facility compliance, not efficacy or safety concerns. I remain bullish on ACHV,…
defenseworld.net Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Rating of “Buy” from Brokerages Achieve Life Sciences, Inc. (NASDAQ: ACHV - Get Free Report) has received a consensus rating of "Buy" from the eight research firms that are currently covering the firm, MarketBeat.com reports. One…
defenseworld.net Frazier Life Sciences Management L.P. Buys New Stake in Achieve Life Sciences, Inc. $ACHV Frazier Life Sciences Management L.P. purchased a new position in Achieve Life Sciences, Inc. (NASDAQ: ACHV) in the undefined quarter, according to the company in its most recent Form 13F filing with…
globenewswire.com Achieve Life Sciences Announced Granting of New Hire Inducement Awards SEATTLE and VANCOUVER, British Columbia, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development…
defenseworld.net Deutsche Bank AG Makes New $506,000 Investment in Achieve Life Sciences, Inc. $ACHV Deutsche Bank AG purchased a new position in Achieve Life Sciences, Inc. (NASDAQ: ACHV) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and…
globenewswire.com Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates Closed a private placement of up to $354 million, with $180 million upfront and up to $174 million from warrants exercisable prior to and up to 20 trading days following FDA approval Strengthened…
globenewswire.com Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality SEATTLE and VANCOUVER, British Columbia, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused…
globenewswire.com Achieve Life Sciences Announced Granting of New Hire Inducement Awards SEATTLE and VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development…
defenseworld.net Achieve Life Sciences (NASDAQ:ACHV) Shares Up 6.5% – Here’s Why Achieve Life Sciences, Inc. (NASDAQ: ACHV - Get Free Report) was up 6.5% during mid-day trading on Friday. The stock traded as high as $6.33 and last traded at $6.35. 209,257 shares were traded…
marketbeat.com Achieve Life Sciences Stockholders Weigh Board Slate, Share Increase at Annual Meeting Achieve Life Sciences NASDAQ: ACHV held its 2026 Annual Meeting of Stockholders virtually, with Chief Executive Officer Andrew Goldberg serving as chairperson of the meeting. Goldberg called the…
seekingalpha.com Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able The last months were eventful for Achieve Life Sciences, sending the stock strongly down, but later to a new high for the year, implying optimism about the future path. Achieve is, in my view, a more…
